These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 17922993

  • 1. [The prospective study of the clinical features and outcome of HBeAg-negative and HBeAg-positive cirrhosis in patients with chronic type B hepatitis].
    Ma H, Guo F, Wei L, Sun Y, Wang H.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 10; 87(26):1832-5. PubMed ID: 17922993
    [Abstract] [Full Text] [Related]

  • 2. Clinical features and survival in Chinese patients with hepatitis B e antigen-negative hepatitis B virus-related cirrhosis.
    Ma H, Wei L, Guo F, Zhu S, Sun Y, Wang H.
    J Gastroenterol Hepatol; 2008 Aug 10; 23(8 Pt 1):1250-8. PubMed ID: 18624896
    [Abstract] [Full Text] [Related]

  • 3. [The impact of HBeAg positivity/negativity and HBV DNA loads on the prognosis of chronic severe hepatitis B].
    Sun QF, Lü Y, Xu DZ, Lan XY, Liu JY, Sun XJ.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jun 10; 14(6):410-3. PubMed ID: 16792862
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].
    Kim KH, Na IH, Cha JM, Cho YK, Park SY, Kim HP, Song CS, Heo J, Cho M.
    Taehan Kan Hakhoe Chi; 2003 Dec 10; 9(4):284-92. PubMed ID: 14695695
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.
    Viganò M, Colombo M, Aroldi A, Lunghi G, Manenti E, Ponticelli C, Lampertico P.
    Antivir Ther; 2005 Dec 10; 10(6):709-13. PubMed ID: 16218169
    [Abstract] [Full Text] [Related]

  • 8. Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation.
    Dai CY, Yu ML, Hsieh MY, Lee LP, Hou NJ, Huang JF, Chen SC, Lin ZY, Hsieh MY, Wang LY, Tsai JF, Chang WY, Chuang WL.
    Liver Int; 2007 Dec 10; 27(10):1364-70. PubMed ID: 17900250
    [Abstract] [Full Text] [Related]

  • 9. e-antigen-negative chronic hepatitis B in Bangladesh.
    Ahmad N, Alam S, Mustafa G, Adnan AB, Baig RH, Khan M.
    Hepatobiliary Pancreat Dis Int; 2008 Aug 10; 7(4):379-82. PubMed ID: 18693173
    [Abstract] [Full Text] [Related]

  • 10. Characteristics of patients with chronic hepatitis B in France: predominant frequency of HBe antigen negative cases.
    Zarski JP, Marcellin P, Leroy V, Trepo C, Samuel D, Ganne-Carrie N, Barange K, Canva V, Doffoel M, Cales P, Fédération nationale des Pôles de référence et des Réseaux Hépatites.
    J Hepatol; 2006 Sep 10; 45(3):355-60. PubMed ID: 16750585
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lamivudine monotherapy in HBeAg-negative chronic hepatitis B: prediction of response-breakthrough and long-term clinical outcome.
    Manolakopoulos S, Bethanis S, Elefsiniotis J, Karatapanis S, Triantos C, Sourvinos G, Touloumi G, Economou M, Vlachogiannakos J, Spandidos D, Avgerinos A, Tzourmakliotis D.
    Aliment Pharmacol Ther; 2006 Mar 15; 23(6):787-95. PubMed ID: 16556181
    [Abstract] [Full Text] [Related]

  • 13. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
    Manesis EK, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ.
    Am J Gastroenterol; 2003 Oct 15; 98(10):2261-7. PubMed ID: 14572577
    [Abstract] [Full Text] [Related]

  • 14. Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine.
    Di Marco V, Marzano A, Lampertico P, Andreone P, Santantonio T, Almasio PL, Rizzetto M, Craxì A, Italian Association for the Study of the Liver (AISF) Lamivudine Study Group, Italy.
    Hepatology; 2004 Oct 15; 40(4):883-91. PubMed ID: 15382125
    [Abstract] [Full Text] [Related]

  • 15. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV, Manolakopoulos S, Touloumi G, Vourli G, Raptopoulou-Gigi M, Vafiadis-Zoumbouli I, Vasiliadis T, Mimidis K, Gogos C, Ketikoglou I, Manesis EK, HEPNET. Greece Cohort Study Group.
    Gut; 2011 Aug 15; 60(8):1109-16. PubMed ID: 21270118
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
    Dai CY, Chuang WL, Hou NJ, Lee LP, Hsieh MY, Lin ZY, Chen SC, Huang JF, Hsieh MY, Wang LY, Tsai JF, Wen-Yu, Yu ML.
    Clin Ther; 2006 Dec 15; 28(12):2081-92. PubMed ID: 17296464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.